Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Guidelines in ovarian cancer
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer
Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer
